We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Series D Financing

News List

Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms prnasia
May 18, 2021
Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital.
Sirnaomics seals $105m Series D financing for RNAi therapeutics pharmaceutical-business-review
October 28, 2020
Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed its USD$105 million Series D financing.
Orca Bio raises $192m to support cell therapies development pharmaceutical-technology
June 19, 2020
US-based biotechnology firm Orca Bio has raised $192m in a Series D financing round to support the development of cell therapies intended to provide an alternative for standard bone marrow transplants.
Promethera Biosciences completes €39.7 M Series D Financing biospectrumasia
May 09, 2019
The round was co-led by new Japanese investors ITOCHU Corporation